" /> PIM Kinase Inhibitor LGH447 - CISMeF





Preferred Label : PIM Kinase Inhibitor LGH447;

NCIt related terms : LGH-447;

NCIt definition : An orally available pan-PIM protein kinase inhibitor with potential antineoplastic activity. PIM kinase inhibitor LGH447 binds to and inhibits the activities of PIM-1, -2 and -3 serine/threonine kinases, which may result in the interruption of the G1/S phase cell cycle transition, the expression of the pro-apoptotic Bcl2 protein and tumor cell apoptosis in cells that overexpress PIMs. PIM kinases, downstream effectors of many cytokine and growth factor signaling pathways, play key roles in cell cycle progression and apoptosis inhibition and may be overexpressed in various malignancies.;

UNII : 9TG5O4V25H;

InChIKey : VRQXRVAKPDCRCI-ZNMIVQPWSA-N;

CAS number : 1210608-43-7; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1210608-43-7 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : LGH-447; PIM-447; PIM 447;

NCI Metathesaurus CUI : CL433893;

Details


You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.